Annual Accounts Payable
$1.51 M
+$725.00 K+92.01%
December 31, 2023
Summary
- As of February 12, 2025, ATXS annual accounts payable is $1.51 million, with the most recent change of +$725.00 thousand (+92.01%) on December 31, 2023.
- During the last 3 years, ATXS annual accounts payable has fallen by -$31.00 thousand (-2.01%).
- ATXS annual accounts payable is now -2.83% below its all-time high of $1.56 million, reached on December 31, 2021.
Performance
ATXS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.28 M
-$1.06 M-45.41%
September 30, 2024
Summary
- As of February 12, 2025, ATXS quarterly accounts payable is $1.28 million, with the most recent change of -$1.06 million (-45.41%) on September 30, 2024.
- Over the past year, ATXS quarterly accounts payable has increased by +$140.00 thousand (+12.30%).
- ATXS quarterly accounts payable is now -48.59% below its all-time high of $2.49 million, reached on June 30, 2015.
Performance
ATXS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ATXS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +92.0% | +12.3% |
| 3 y3 years | -2.0% | +12.3% |
| 5 y5 years | +7.5% | +12.3% |
ATXS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.8% | +92.0% | -45.4% | +62.2% |
| 5 y | 5-year | -2.8% | +92.0% | -45.4% | +122.7% |
| alltime | all time | -2.8% | +132.4% | -48.6% | +122.7% |
Astria Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.28 M(-45.4%) |
| Jun 2024 | - | $2.34 M(+171.6%) |
| Mar 2024 | - | $862.00 K(-43.0%) |
| Dec 2023 | $1.51 M(+92.0%) | $1.51 M(+33.0%) |
| Sep 2023 | - | $1.14 M(+37.3%) |
| Jun 2023 | - | $829.00 K(-10.9%) |
| Mar 2023 | - | $930.00 K(+18.0%) |
| Dec 2022 | $788.00 K(-49.4%) | $788.00 K(-0.3%) |
| Sep 2022 | - | $790.00 K(-20.6%) |
| Jun 2022 | - | $995.00 K(+6.9%) |
| Mar 2022 | - | $931.00 K(-40.2%) |
| Dec 2021 | $1.56 M(+0.8%) | $1.56 M(+171.3%) |
| Sep 2021 | - | $574.00 K(-7.3%) |
| Jun 2021 | - | $619.00 K(-65.8%) |
| Mar 2021 | - | $1.81 M(+17.2%) |
| Dec 2020 | $1.54 M(+29.0%) | $1.54 M(+9.7%) |
| Sep 2020 | - | $1.41 M(+20.4%) |
| Jun 2020 | - | $1.17 M(+64.9%) |
| Mar 2020 | - | $709.00 K(-40.8%) |
| Dec 2019 | $1.20 M | $1.20 M(-44.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $2.16 M(+55.1%) |
| Jun 2019 | - | $1.39 M(-12.5%) |
| Mar 2019 | - | $1.59 M(+12.8%) |
| Dec 2018 | $1.41 M(+82.1%) | $1.41 M(+34.5%) |
| Sep 2018 | - | $1.05 M(+33.4%) |
| Jun 2018 | - | $785.00 K(-29.6%) |
| Mar 2018 | - | $1.11 M(+44.2%) |
| Dec 2017 | $773.00 K(-45.0%) | $773.00 K(-35.7%) |
| Sep 2017 | - | $1.20 M(-41.5%) |
| Jun 2017 | - | $2.06 M(+118.2%) |
| Mar 2017 | - | $942.00 K(-33.0%) |
| Dec 2016 | $1.41 M(+5.8%) | $1.41 M(-18.4%) |
| Sep 2016 | - | $1.72 M(+10.4%) |
| Jun 2016 | - | $1.56 M(-4.1%) |
| Mar 2016 | - | $1.63 M(+22.4%) |
| Dec 2015 | $1.33 M(+17.3%) | $1.33 M(-25.5%) |
| Sep 2015 | - | $1.78 M(-28.3%) |
| Jun 2015 | - | $2.49 M(+23.0%) |
| Mar 2015 | - | $2.02 M(+78.5%) |
| Dec 2014 | $1.13 M(+73.9%) | $1.13 M |
| Dec 2013 | $651.00 K | - |
FAQ
- What is Astria Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Astria Therapeutics?
- What is Astria Therapeutics annual accounts payable year-on-year change?
- What is Astria Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Astria Therapeutics?
- What is Astria Therapeutics quarterly accounts payable year-on-year change?
What is Astria Therapeutics annual accounts payable?
The current annual accounts payable of ATXS is $1.51 M
What is the all time high annual accounts payable for Astria Therapeutics?
Astria Therapeutics all-time high annual accounts payable is $1.56 M
What is Astria Therapeutics annual accounts payable year-on-year change?
Over the past year, ATXS annual accounts payable has changed by +$725.00 K (+92.01%)
What is Astria Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ATXS is $1.28 M
What is the all time high quarterly accounts payable for Astria Therapeutics?
Astria Therapeutics all-time high quarterly accounts payable is $2.49 M
What is Astria Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ATXS quarterly accounts payable has changed by +$140.00 K (+12.30%)